Compare GSK plc (GSK) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Stitch Fix Inc — how do they compare? GSK plc trades at $46.5 (market cap $91.88B), while Stitch Fix Inc trades at $2.84 (market cap $366.07M). The key difference: GSK plc is far larger — about 251× Stitch Fix Inc's market cap, and GSK plc pays a 3.9% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Stitch Fix Inc for 31 Days on average.
| GSK | SFIX | |
|---|---|---|
Market Cap | $91.88B | $366.07M |
Volume | 7,730,529 | 5,152,008 |
Sector | Health | Consumer Cyclical |
52-Week High | $61.18 | $5.64 |
52-Week Low | $43.24 | $2.16 |
Typical Hold Time | 93 Days | 31 Days |
Enterprise Value | $111.88B | $261.88M |
Dividend Yield | 3.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.54, down 1.02% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.36 exceeding the $1.27 estimate. Fundamentals show robust profitability with a 72.73% gross margin and 14.52% net margin, while valuation metrics like a P/E of 14.89 appear reasonable. Recent news highlights pipeline advancements, including a $750 million cancer therapy deal and strategic focus on oncology and cost savings.
The outlook is mixed; analyst consensus leans Hold (55.18%) with a minority Buy rating (31.03%), reflecting caution amid an approaching HIV patent cliff. Near-term support is at $45, with resistance at $47. Revenue growth to $33.2B in 2026 and a dividend of $0.45 per share offer stability, but execution risks and competitive pressures remain key watchpoints for investors.
Stitch Fix (SFIX) trades at $2.73, showing no change in the latest session. The stock faces bearish technical signals with recent earnings beats overshadowed by weak forward guidance. Revenue has stabilized around $1.3 billion, but profitability remains elusive with negative net income margins. Recent news highlights multiple law firm investigations and a significant post-earnings decline due to cautious fiscal 2027 outlook.
The outlook remains challenging with Wall Street showing cautious sentiment (24% buy ratings). While AI initiatives show promise for customer engagement, declining active clients and ongoing profitability concerns present significant headwinds. The consensus price target of $3.40 suggests limited upside potential amid execution risks and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
